Eli Lilly, Mallinckrodt Earnings Top; Shares Pop [Investor's Business Daily]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Investors Business Daily
Related news Pharmaceutical companies Eli Lilly ( LLY ) and Mallinckrodt ( MNK ) reported third-quarter earnings on Tuesday. In premarket trading on the stock market today , Eli Lilly stock were not yet active after popping 3.2% on Monday. Also in early action on stock market , Mallinckrodt stock climbed 3.1%. For its third quarter, Lilly earnings per share excluding items of $1.39 a share on revenue of $6.06 billion. In the year-ago period, the pharma posted adjusted of $1.05 a share and $5.66 billion in sales. The consensus of analysts polled by Zacks Investment Research called for adjusted profit of $1.37 a share and $6.11 billion in sales. Lilly guided to full-year EPS of $5.55 to $5.60 and revenue of $24.3 billion and $24.5 billion. Analysts estimated adjusted income of $5.47 per share on $24.48 billion in revenue. Mallinckrodt earnings rose to $2.10 a share on $640 million in sales for its third period. At this time last year, the pharmaceutical outlet posted adjusted income of
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says [Yahoo! Finance]Yahoo! Finance
- New Weight-Loss, Diabetes Drugs Reach One in Eight Americans [BNN Bloomberg (Canada)]BNN Bloomberg
- 3 Stocks to Buy Following Guidance Upgrades [Yahoo! Finance]Yahoo! Finance
- The finance chief of this biotech company is a Harvard-trained neuroscientist who says ‘the modern day CFO needs to speak the language of the team' [Fortune]Fortune
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form SD
- 4/30/24 - Form 10-Q
- LLY's page on the SEC website